Skip to main content
Clinical Trials/NCT02588222
NCT02588222
Completed
Not Applicable

GRINCH: Groningen Initiative on Reference Intervals in Children

University Medical Center Groningen1 site in 1 country120 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammatory Bowel Disease
Sponsor
University Medical Center Groningen
Enrollment
120
Locations
1
Primary Endpoint
Levels of Calgranulin C (S100A12) in healthy children
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to establish reliable reference intervals for fecal S100A12 in healthy children.

Detailed Description

RATIONALE S100A12 (calgranulin C) is a cytoplasmic protein secreted exclusively by activated neutrophils. It can be measured in stools and elevated levels are observed in children with inflammatory bowel disease. The protein is stable in stool samples for up to seven days at room temperature, which allows collection at home and potential delays in transport to the laboratory. S100A12 could be used as a marker to discriminate between pediatric inflammatory and functional gastro-intestinal conditions, and prevent children with a low probability of inflammation from unnecessary endoscopic procedures. Until now a reliable reference interval for healthy children is lacking. OBJECTIVE To establish reliable reference intervals for fecal S100A12 in healthy children. TIME FRAME Healthy children will be asked to send in one feces sample anonymously during the inclusion period. The investigators expect that the required 120 samples will be collected before December 2015. There will be no follow up of patients.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
May 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

P.F. van Rheenen

Dr.

University Medical Center Groningen

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Treated for any gastro-intestinal symptoms
  • Diarrhea in the last week before the collection of the feces sample
  • Fever in the last week before collection of the feces sample
  • Use of NSAIDs of Proton pump inhibitors in the last 14 days before collection feces sample.

Outcomes

Primary Outcomes

Levels of Calgranulin C (S100A12) in healthy children

Time Frame: One measurement at baseline

Study Sites (1)

Loading locations...

Similar Trials